NCT05544123View on ClinicalTrials.gov

The Treatment Situation of Chinese County Population With Breast Cancer

UnknownOBSERVATIONAL
Enrollment

2,500

Participants

Timeline

Start Date

September 29, 2022

Primary Completion Date

August 31, 2023

Study Completion Date

September 30, 2024

Conditions
Breast CancerBreast CarcinomaBreast Tumor
Interventions
OTHER

pathological stage

breast cancer molecular subtyping and pathological TNM stage

Trial Locations (2)

453100

NOT_YET_RECRUITING

The First Affiliated Hospital of Xinxiang Medical University, Xinxiang

RECRUITING

路平, Xinxiang

Sponsors

Collaborators (1)

AstraZeneca
All Listed Sponsors
collaborator

AstraZeneca

INDUSTRY

lead

The First Affiliated Hospital of Xinxiang Medical College

OTHER